Passage Bio
PASG
PASG
108 hedge funds and large institutions have $133M invested in Passage Bio in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.08% less ownership
Funds ownership: 4.04% → 3.96% (-0.08%)
52% less capital invested
Capital invested by funds: $278M → $133M (-$144M)
Holders
108
Holding in Top 10
3
Calls
$35K
Puts
$8K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$1.14M | |
| 3 | +$1.1M | |
| 4 |
Renaissance Technologies
New York
|
+$931K |
| 5 |
JPMorgan Chase & Co
New York
|
+$571K |
Top Sellers
| 1 | -$31.8M | |
| 2 | -$4.38M | |
| 3 | -$4.35M | |
| 4 |
Morgan Stanley
New York
|
-$2.76M |
| 5 |
BlackRock
New York
|
-$616K |